{"ticker": {"uuid": "2af9d6f2-45a0-4e5c-a518-c182a3d4ad61", "symbol": "CERS", "name": "Cerus Corporation", "exchange": "NASDAQ", "country": "US", "sector": "Healthcare", "industry": "Medical Devices"}, "articles": [{"title": "Cerus Corporation to release Q2 2026 results on July 30", "summary": "Cerus Corporation is scheduled to announce its Q2 2026 financial results on July 30, 2026, after the stock market closes. This will be followed by a conference call and webcast at 4:30 P.M. ET to discuss the financial performance, business overview, and future outlook. A replay o", "url": "https://scanx.trade/stock-market-news/companies/cerus-corporation-to-release-q2-2026-results-on-july-30/45782115", "source_name": "scanx.trade", "published_at": "2026-07-16T21:10:47", "published_display": "16 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cerus-corporation-release-second-quarter-200100064.html", "source_name": "Business Wire", "published_at": "2026-07-16T20:01:00+00:00", "published_display": "16 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus to Discuss Results and Outlook in July 30 Webcast", "summary": "Cerus Corporation announced it will release its second-quarter 2026 financial results on Thursday, July 30, 2026, after the stock market closes. The company will host a conference call and webcast at 4:30 P.M. ET to discuss these results and provide a business overview and outloo", "url": "https://www.stocktitan.net/news/CERS/cerus-corporation-to-release-second-quarter-2026-financial-results-kvbsr8s5pbay.html", "source_name": "Stock Titan", "published_at": "2026-07-16T20:10:47", "published_display": "16 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026", "summary": "Vivek K. Jayaraman, a CERS shareholder, has filed a Form 144 to announce the planned sale of up to 16,666 shares of CERS common stock on July 16, 2026, with an estimated market value of $52,664.56. These shares are restricted stock acquired on March 12, 2021. The filing also disc", "url": "https://www.stocktitan.net/sec-filings/CERS/144-cerus-corp-sec-filing-2fbbeb603b2f.html", "source_name": "Stock Titan", "published_at": "2026-07-16T20:10:47", "published_display": "16 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman", "summary": "Cerus Corporation has updated the employment terms for William Greenman following his transition to Executive Chairman, effective July 1, 2026. He will serve until May 31, 2027, with a reduced time commitment, and will receive an annual base salary of $500,000, plus an 80% target", "url": "https://www.stocktitan.net/sec-filings/CERS/8-k-cerus-corp-reports-material-event-7884114f4c14.html", "source_name": "Stock Titan", "published_at": "2026-07-11T01:09:43", "published_display": "11 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus(CERS) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wJBVV95cUxPYzdCSGhXU0ZtVHhRQ2RfU3pDbm1kWWpPWXU5Sk1pVDh5X2J6cVNHTGhoNDdNNFVMUmRiakpaZHlTNzlDTVpoc1h6NnN0bkZXVV9kZlc3cjV3SUVQakhsaEhsNEpyUnBEN1VKR3NpeHJCNjRacWMxUlI1QUJXQ0M5YmcycjRCbDJhcldrQ0F6X1l3VVp5ZGJlLUc1RmxUVGxJRXVWUDVuaWRBQUF5TWptMUpWQ1dsMWxTOG5wSC1adDBDZV9CT2oyZWVjN3d0OXNna3d5d0U5M3dMbjJZMHJZLWh5azV2TkFNRDZzS1lxY3Zsakw3bnk1WGtmQm9MVFVMTmxEUkJQcDU0RXJnejA1WU5ycUoyYUloWG9vLUJDN0lqT3NtQ0pTTTZ3V0s4bFZzbzc5VXNLS29jVVZLeEJlZWk5bWRYS2ZoWjRiZWE1amx4QTZZSTFQLUhzSQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-09T17:30:11+00:00", "published_display": "09 Jul 2026 17:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp faces a complex landscape as blood safety technology evolves", "summary": "Cerus Corp operates in the demanding healthcare environment of blood safety systems, focusing on pathogen reduction technology. The company's success relies on the adoption of its systems by blood centers and hospitals, which face regulatory scrutiny, budget constraints, and evol", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cerus-corp-faces-a-complex-landscape-as-blood-safety-technology-evolves/69732085", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T13:46:54", "published_display": "09 Jul 2026 13:46", "sentiment": "positive", "sentiment_pct": 63, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp updates focus on blood safety. Business model supports long-term growth", "summary": "Cerus Corp (CERS) focuses on developing medical technologies to enhance blood transfusion safety, particularly through its pathogen reduction systems for platelets and plasma. The company, listed on Nasdaq, aims to reduce the risk of infection from transfused blood components for", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cerus-corp-updates-focus-on-blood-safety-business-model-supports/69724230", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T14:09:32", "published_display": "08 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp looks to blood safety technology as investors weigh long-term growth", "summary": "Cerus Corp specializes in pathogen reduction systems for blood components, enhancing transfusion safety globally. The company's business model focuses on expanding its technology and partnerships with healthcare providers and blood centers. Investors are keenly watching the long-", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cerus-corp-looks-to-blood-safety-technology-as-investors-weigh-long-term/69715969", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T16:39:46", "published_display": "07 Jul 2026 16:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CERS - Cerus Corp Latest SEC Filings", "summary": "This article provides comprehensive financial data and market performance metrics for Cerus Corp (CERS), highlighting its latest stock price, financial ratios, sales figures, and insider transaction details. It offers a snapshot of the company's current market position, including", "url": "https://finviz.com/stock?t=CERS&p=d&ty=lf&b=1&r=y1&page=13", "source_name": "Finviz", "published_at": "2026-07-06T00:39:46", "published_display": "06 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp chief legal officer Chrystal Jensen sells $71,597 in stock", "summary": "Chrystal Jensen, Chief Legal Officer at Cerus Corp (NASDAQ:CERS), sold 24,329 shares of common stock totaling $71,597 on June 30, 2026. These sales were not discretionary but rather to cover tax withholding obligations and brokerage fees related to restricted stock unit vesting. ", "url": "https://www.investing.com/news/insider-trading-news/cerus-corp-chief-legal-officer-chrystal-jensen-sells-71597-in-stock-93CH-4774747", "source_name": "Investing.com", "published_at": "2026-07-03T23:40:36", "published_display": "03 Jul 2026 23:40", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes", "summary": "Cerus COO Vivek Jayaraman sold $124,658 worth of company stock to cover tax withholding obligations associated with the vesting of restricted stock units. This transaction, occurring on June 30, 2026, involved the sale of 42,359 shares at an average price of $2.9429. Additionally", "url": "https://za.investing.com/news/stock-market-news/cerus-coo-vivek-jayaraman-disposes-of-124658-in-stock-for-taxes-93CH-4354954", "source_name": "Investing.com South Africa", "published_at": "2026-07-03T11:10:10", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus CFO Kevin Green sells $99,105 in CERS shares", "summary": "Cerus CFO Kevin Green sold 33,676 shares of CERS stock for $99,105 on June 30, 2026, under a pre-arranged trading plan to cover tax obligations from restricted stock unit vesting, not as a discretionary sale. Following these transactions, Green directly holds 1,062,188 shares. Th", "url": "https://www.investing.com/news/insider-trading-news/cerus-cfo-kevin-green-sells-99105-in-cers-shares-93CH-4774744", "source_name": "Investing.com", "published_at": "2026-07-03T11:10:10", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) CFO logs tax-related share sale and new stock grant", "summary": "Cerus Corp's CFO, Kevin Dennis Green, reported a non-discretionary sale of 33,676 shares at a weighted average price of $2.94 to cover tax withholding and brokerage fees related to restricted stock unit vesting. On the same date, he also received a grant of 63,600 shares at no co", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-0610e00e1c00.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:40:25", "published_display": "02 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) COO granted RSUs, performance rights and sells shares", "summary": "Cerus Corp's COO, Vivek K. Jayaraman, received significant equity grants including 554,529 shares of common stock and 369,686 performance rights, with vesting contingent on continued service and the company's stock performance. Concurrently, he sold 42,359 shares worth approximat", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-d9960180595b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:40:25", "published_display": "02 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant", "summary": "Cerus Corp's Chief Legal Officer, Chrystal Jensen, reported two common stock transactions on June 30, 2026. Jensen sold 24,329 shares at a weighted average price of $2.9429 to cover tax withholding obligations and brokerage fees related to vesting restricted stock units under a R", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-6afca42325b7.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:40:25", "published_display": "02 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant", "summary": "CERUS (CERS) President and CEO William Mariner Greenman reported a tax-related sale of 101,919 shares to cover withholding and brokerage fees, alongside receiving a grant of 192,500 shares at no cost. These transactions, conducted under a Rule 10b5-1 plan, resulted in a net incre", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-803acf48e8f1.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:09:24", "published_display": "02 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Institutional Confidence", "summary": "Cerus Corp (CERS) has an institutional shareholding score of 7.00, placing it 79th out of 203 in the Healthcare Equipment & Supplies industry. Institutional investors hold 73.57% of the shares, a slight decrease of 1.81% quarter-over-quarter. Catherine Wood is the largest institu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T17:10:14", "published_display": "18 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Cerus Corp (CERS) currently holds a financial score of 8.05, placing it 48th out of 203 in the Healthcare Equipment & Supplies industry, indicating stable financial health and high operating efficiency. The company recently reported a quarterly revenue of $59.89 million, marking ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:30", "published_display": "18 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress", "summary": "Cerus Corporation announced its participation in the 39th International ISBT Congress in Kuala Lumpur, Malaysia, from June 20-24, 2026. The company will host a symposium and present abstracts highlighting the INTERCEPT Blood System's role in enhancing blood safety, operational ef", "url": "https://finance.yahoo.com/healthcare/articles/cerus-showcase-evidence-innovation-global-123000733.html", "source_name": "Market source", "published_at": "2026-06-18T05:09:30", "published_display": "18 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Cerus Corp (CERS), detailing its current price momentum, support and resistance levels, and signals from various technical indicators and moving averages. The stock is currently trading between resistance at $3.08 and support at $2.36", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/technical", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:30", "published_display": "18 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Cerus Corp (CERS) has an earnings forecast score of 8.67, ranking 16th in the Healthcare Equipment & Supplies industry, with an average analyst price target of $5.00. Based on ratings from 3 analysts, the stock has a \"Buy\" trend. The expected revenue for the next quarter is $60.9", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:03:00", "published_display": "18 Jun 2026 04:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Cerus Corp (CERS) based on its business segments and regional contributions. For the fiscal year 2025, Product revenue accounted for 88.17% ($206.13M) and Government Contract revenue for 11.83% ($27.66M). Geographically, the ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T21:13:07", "published_display": "17 Jun 2026 21:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Cerus Corp (CERS), highlighting major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and a list of key shareholder activities with changes i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T14:09:35", "published_display": "17 Jun 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Cerus Corp (CERS)'s dividend and stock split history, noting that the company has distributed $0.00 in dividends over the past five years and has no recorded stock splits. It also includes current stock performance metrics such as a +8.50% gai", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T13:09:35", "published_display": "17 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus takes INTERCEPT blood system data to global transfusion congress", "summary": "Cerus Corporation (Nasdaq: CERS) announced its participation in the 39th International ISBT Congress in Kuala Lumpur, Malaysia, from June 20-24, 2026. The company will host a symposium and present abstracts highlighting the INTERCEPT Blood System's effectiveness in enhancing bloo", "url": "https://www.stocktitan.net/news/CERS/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-pmi2meq1qbo6.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:09:34", "published_display": "17 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M", "summary": "Cerus Corporation has secured a new debt facility of up to $110 million with MidCap Financial, combining a five-year term loan with an asset-backed revolving loan. This refinancing is expected to reduce annual cash interest expenses by up to $3.5 million and lowers the outstandin", "url": "https://finance.yahoo.com/markets/stocks/articles/cerus-corporation-cers-closes-debt-125301266.html", "source_name": "Market source", "published_at": "2026-06-16T12:39:19", "published_display": "16 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "5 Best Genomics Stocks to Buy According to Analysts", "summary": "This article identifies Cerus Corporation (NASDAQ: CERS) as a top genomics stock to buy, with analysts projecting a 66.05% upside potential. Cerus recently secured a new debt facility of up to $110 million, which is expected to cut annual cash interest expenses by up to $3.5 mill", "url": "https://www.insidermonkey.com/blog/5-best-genomics-stocks-to-buy-according-to-analysts-1780200/3/", "source_name": "Insider Monkey", "published_at": "2026-06-14T11:15:00", "published_display": "14 Jun 2026 11:15", "sentiment": "positive", "sentiment_pct": 73, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation Closes New Debt Facility of Up to $110 Million", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cerus-corporation-closes-debt-facility-123000605.html", "source_name": "Business Wire", "published_at": "2026-06-08T12:30:00+00:00", "published_display": "08 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Cerus (CERS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9zWDNZR2Q1aGh2akVQSU1VbGJNeDY4eHJtVEd4ZzdmaWV1dkFfYjNJd2c3LVpla2w2VVMzOXVkaHZvZHZua2thR2doLWtIZUFlTUc4YVUyTGdsdy1sVG8ycjAtdC1hQlVRZkQwcg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Significant Cerus shareholder to oppose CEO and pay chair at June 2 vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQW53MnhYTmU1bDRsU1NTS0FEOURPbnVYWDFpSzlNV05ZNlQwMFVHeFdCcXJhNmpmWmM4SWlfTFBCY1lTM3NTLUpraEQ1dmVPa29nRFItTmxoclJxTWxHOFNrWjRUZkgwTnFCLWpocFNGWXVqWE1UNGVsUlhfNVgzRFlCMlcyN1Nack5Xb0NJZVVyOXBzNzRiVThVRjJxaGdkRmc2UkV1QTZWTjdPUnFYWE9xWFV2ZTYydmR5bm5R?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSXBzZklWbjJFTHpsSjZwTjQ3ZHcxb2tGeVRaNUlFaG1ESEJZN2JJUTRNcVBiNkRZVHZKcVlEa21LeFEyc2pXMmhVbVZZUFFXV0M3b0YxcHdDZzh3MVYtbEF4RTJqM2ZMVGhaYXp3czVNTUJoT1RYaDE4cWVRbmc4a3pSZTk2MS1Zb2N4R3pEME5odkVSemlDSEhmRWFRYzJOVlZhT2NONS0?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis (NASDAQ:CERS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOdVBuY1VHWnBHeDdoQVRkdGEwc2FmV0t0UG92a2JWOWZvNlM2T29JQk1LcDBuWnJ2UV9BS05KQnlobGY5amx4X245bWlUZzZSbk9tR3FhVHlHeUFHYjZmRHctNFF0QjMydHhlYjVyWXFzTHhvdWdNUjBqcGFLTUpWSTFucXNtNFl0V19xMnQ2OVlYdkludzV6QXEtendMRWNENFg2QUtUSFJhZjg1V0FDaXdISQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/d5ab6c75-7b71-3df5-b161-3c5f91b420d6/cerus-corporation-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-01T12:30:00+00:00", "published_display": "01 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cerus-corp-cers-q1-2026-071759355.html", "source_name": "GuruFocus.com", "published_at": "2026-05-01T07:17:59+00:00", "published_display": "01 May 2026 07:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQNnRSUzJILXdnN2h4a2RUNEFSMFZkbUx4TlViOW9SME1uMktvS0Rzbmw0STd5bDJDYmpJcm5VNVV4dUtRX0g2RmMxOUV0Zk5UdVM3dExYX2wtQVFfYXNOM1dIazFQLTFKbTJZNndZNVliblQ3ekVnVVpnOXZtZWU1dVFVakN4LVlFVkwtRW9iLXZQSmhHTFYxUm5xTVF5UQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation Announces First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQYjRjWmtvX09RMlZiQ1Z6ZTE5RzgyZU5hOVlmcjhRanZ4aFFIMGwzQUUzOFdJOExhYWw4LU14SEFzY29SMU9rbVZUc3VhR1o4QURtR0VpNm4tMGUtTlZWbXRZU0FIaEZ6bFlOWmM2UXNfSjU3SGRINUctcExfTnFaZTJMMEo1VnRWYlRpNDVaMTNKQ1JMTzJ1Q21DaWpyX1p4cUNyNnhxUWgxWWhWSkFSeFRBcS15MWh3LXhOejF3?oc=5", "source_name": "Business Wire", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus wins 4-year deal with French blood network serving 330,000 units", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNUG1iM3NNVnJXMVZyMHQ1WkJQNnExSU92Y3J3Y1A0Z0Q4b3ZYQnUxUlFRcUQyZVZkbGI3NHNpYl81V190X1paS3pWbzlxV1puTVdpMmZ0anc5di1aQ2lIUmZpd0c5YV9LblJuYkg3VGY1d28xNGxuNHBBX1dYVU1UeDBYN2NxMFU0RVQtLTYxSTRzSGxsSjIwVEhHNG1Ldjg5cmJ0MGVmWjBFdUNhRHRrMTl0YjhESUR5UVE?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cerus' Record 2025 Sets It Up For Another Leg Higher (NASDAQ:CERS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQQzg4SWx0N1plVVg2TTBaMjNYZEtnZnFfalpNUFk1RFpzZTY2ekdXUmVlcXhDeVFQUXdGaEZCT19LYnllcF9DMFU2RW5pTUFPTkhjZ0JSVzhIT0N0YU1fTjREdzlFVFozOGx5Uk5rSjhJbEZYbnBMVUREdUxVaDFaZG5TamJKQ1NsZkhHZmRUaE5GLXVYNW9J?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOXzRWMWVJQjBISUp5U2JSSDlqQmYxdHVSMnF4U0JmSDJNTy1NR3hfSzgxV3pNYVFrX1oxME1EVjM4LUQ5V2Q5TV9zVHUyaXV3OU9IYURjRVVoS1NDd29ET0I1Z2VPV0hMXzJ6X09BWnYzVkJqaVhIMlh3bGs4dUxwRnZGZVhyRnpIclg4QUhscDlDZk5PVkJPNw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Cerus Corporation (NASDAQ:CERS) Held Back By Insufficient Growth Even After Shares Climb 27%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Markets Review 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE05aHAtTmIwUmpuLTlaUWs0OHdQY1VMNGxDNjBMMmVLV3d0cVZKazVBNU9tUnZxeXFEdy1DLWttbXdqaEF0SnlSSDZlQmoza19qeE5LSlJNdUdKN2lRRlQ3MVJKMjFTQlk?oc=5", "source_name": "Investing.com", "published_at": "2024-07-15T07:00:00+00:00", "published_display": "15 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) Stock Price, News & Analysis $CERS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5Kd1ZTY3FkTjZ2aUdSWHhhaEl0T2lTZE41LUhsTkRZaDdCQlAtTlpuNG5rUzlCZUZwajdPRXQ3T3FiSmRFV1piY0ZqdzU1UmhDc29xUnl1WXRTZw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-15T18:25:47+00:00", "published_display": "15 Aug 2016 18:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "Cerus Corporation to release Q2 2026 results on July 30", "summary": "Cerus Corporation is scheduled to announce its Q2 2026 financial results on July 30, 2026, after the stock market closes. This will be followed by a conference call and webcast at 4:30 P.M. ET to discuss the financial performance, business overview, and future outlook. A replay o", "url": "https://scanx.trade/stock-market-news/companies/cerus-corporation-to-release-q2-2026-results-on-july-30/45782115", "source_name": "scanx.trade", "published_at": "2026-07-16T21:10:47", "published_display": "16 Jul 2026 21:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation to Release Second Quarter 2026 Financial Results on July 30, 2026", "summary": "", "url": "https://finance.yahoo.com/healthcare/articles/cerus-corporation-release-second-quarter-200100064.html", "source_name": "Business Wire", "published_at": "2026-07-16T20:01:00+00:00", "published_display": "16 Jul 2026 20:01", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus to Discuss Results and Outlook in July 30 Webcast", "summary": "Cerus Corporation announced it will release its second-quarter 2026 financial results on Thursday, July 30, 2026, after the stock market closes. The company will host a conference call and webcast at 4:30 P.M. ET to discuss these results and provide a business overview and outloo", "url": "https://www.stocktitan.net/news/CERS/cerus-corporation-to-release-second-quarter-2026-financial-results-kvbsr8s5pbay.html", "source_name": "Stock Titan", "published_at": "2026-07-16T20:10:47", "published_display": "16 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CERS shareholder (NASDAQ: CERS) details planned stock sales in 2026", "summary": "Vivek K. Jayaraman, a CERS shareholder, has filed a Form 144 to announce the planned sale of up to 16,666 shares of CERS common stock on July 16, 2026, with an estimated market value of $52,664.56. These shares are restricted stock acquired on March 12, 2021. The filing also disc", "url": "https://www.stocktitan.net/sec-filings/CERS/144-cerus-corp-sec-filing-2fbbeb603b2f.html", "source_name": "Stock Titan", "published_at": "2026-07-16T20:10:47", "published_display": "16 Jul 2026 20:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) defines pay and term for William Greenman as Executive Chairman", "summary": "Cerus Corporation has updated the employment terms for William Greenman following his transition to Executive Chairman, effective July 1, 2026. He will serve until May 31, 2027, with a reduced time commitment, and will receive an annual base salary of $500,000, plus an 80% target", "url": "https://www.stocktitan.net/sec-filings/CERS/8-k-cerus-corp-reports-material-event-7884114f4c14.html", "source_name": "Stock Titan", "published_at": "2026-07-11T01:09:43", "published_display": "11 Jul 2026 01:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus(CERS) Stock Options Chain | Quotes & News", "summary": "", "url": "https://news.google.com/rss/articles/CBMi2wJBVV95cUxPYzdCSGhXU0ZtVHhRQ2RfU3pDbm1kWWpPWXU5Sk1pVDh5X2J6cVNHTGhoNDdNNFVMUmRiakpaZHlTNzlDTVpoc1h6NnN0bkZXVV9kZlc3cjV3SUVQakhsaEhsNEpyUnBEN1VKR3NpeHJCNjRacWMxUlI1QUJXQ0M5YmcycjRCbDJhcldrQ0F6X1l3VVp5ZGJlLUc1RmxUVGxJRXVWUDVuaWRBQUF5TWptMUpWQ1dsMWxTOG5wSC1adDBDZV9CT2oyZWVjN3d0OXNna3d5d0U5M3dMbjJZMHJZLWh5azV2TkFNRDZzS1lxY3Zsakw3bnk1WGtmQm9MVFVMTmxEUkJQcDU0RXJnejA1WU5ycUoyYUloWG9vLUJDN0lqT3NtQ0pTTTZ3V0s4bFZzbzc5VXNLS29jVVZLeEJlZWk5bWRYS2ZoWjRiZWE1amx4QTZZSTFQLUhzSQ?oc=5", "source_name": "Moomoo", "published_at": "2026-07-09T17:30:11+00:00", "published_display": "09 Jul 2026 17:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp faces a complex landscape as blood safety technology evolves", "summary": "Cerus Corp operates in the demanding healthcare environment of blood safety systems, focusing on pathogen reduction technology. The company's success relies on the adoption of its systems by blood centers and hospitals, which face regulatory scrutiny, budget constraints, and evol", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cerus-corp-faces-a-complex-landscape-as-blood-safety-technology-evolves/69732085", "source_name": "Ad-hoc-news.de", "published_at": "2026-07-09T13:46:54", "published_display": "09 Jul 2026 13:46", "sentiment": "positive", "sentiment_pct": 63, "event_type": "regulatory", "event_label": "Regulatory and legal", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp updates focus on blood safety. Business model supports long-term growth", "summary": "Cerus Corp (CERS) focuses on developing medical technologies to enhance blood transfusion safety, particularly through its pathogen reduction systems for platelets and plasma. The company, listed on Nasdaq, aims to reduce the risk of infection from transfused blood components for", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cerus-corp-updates-focus-on-blood-safety-business-model-supports/69724230", "source_name": "AD HOC NEWS", "published_at": "2026-07-08T14:09:32", "published_display": "08 Jul 2026 14:09", "sentiment": "positive", "sentiment_pct": 71, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp looks to blood safety technology as investors weigh long-term growth", "summary": "Cerus Corp specializes in pathogen reduction systems for blood components, enhancing transfusion safety globally. The company's business model focuses on expanding its technology and partnerships with healthcare providers and blood centers. Investors are keenly watching the long-", "url": "https://www.ad-hoc-news.de/boerse/news/ueberblick/cerus-corp-looks-to-blood-safety-technology-as-investors-weigh-long-term/69715969", "source_name": "AD HOC NEWS", "published_at": "2026-07-07T16:39:46", "published_display": "07 Jul 2026 16:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CERS - Cerus Corp Latest SEC Filings", "summary": "This article provides comprehensive financial data and market performance metrics for Cerus Corp (CERS), highlighting its latest stock price, financial ratios, sales figures, and insider transaction details. It offers a snapshot of the company's current market position, including", "url": "https://finviz.com/stock?t=CERS&p=d&ty=lf&b=1&r=y1&page=13", "source_name": "Finviz", "published_at": "2026-07-06T00:39:46", "published_display": "06 Jul 2026 00:39", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp chief legal officer Chrystal Jensen sells $71,597 in stock", "summary": "Chrystal Jensen, Chief Legal Officer at Cerus Corp (NASDAQ:CERS), sold 24,329 shares of common stock totaling $71,597 on June 30, 2026. These sales were not discretionary but rather to cover tax withholding obligations and brokerage fees related to restricted stock unit vesting. ", "url": "https://www.investing.com/news/insider-trading-news/cerus-corp-chief-legal-officer-chrystal-jensen-sells-71597-in-stock-93CH-4774747", "source_name": "Investing.com", "published_at": "2026-07-03T23:40:36", "published_display": "03 Jul 2026 23:40", "sentiment": "positive", "sentiment_pct": 69, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus COO Vivek Jayaraman disposes of $124,658 in stock for taxes", "summary": "Cerus COO Vivek Jayaraman sold $124,658 worth of company stock to cover tax withholding obligations associated with the vesting of restricted stock units. This transaction, occurring on June 30, 2026, involved the sale of 42,359 shares at an average price of $2.9429. Additionally", "url": "https://za.investing.com/news/stock-market-news/cerus-coo-vivek-jayaraman-disposes-of-124658-in-stock-for-taxes-93CH-4354954", "source_name": "Investing.com South Africa", "published_at": "2026-07-03T11:10:10", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus CFO Kevin Green sells $99,105 in CERS shares", "summary": "Cerus CFO Kevin Green sold 33,676 shares of CERS stock for $99,105 on June 30, 2026, under a pre-arranged trading plan to cover tax obligations from restricted stock unit vesting, not as a discretionary sale. Following these transactions, Green directly holds 1,062,188 shares. Th", "url": "https://www.investing.com/news/insider-trading-news/cerus-cfo-kevin-green-sells-99105-in-cers-shares-93CH-4774744", "source_name": "Investing.com", "published_at": "2026-07-03T11:10:10", "published_display": "03 Jul 2026 11:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) CFO logs tax-related share sale and new stock grant", "summary": "Cerus Corp's CFO, Kevin Dennis Green, reported a non-discretionary sale of 33,676 shares at a weighted average price of $2.94 to cover tax withholding and brokerage fees related to restricted stock unit vesting. On the same date, he also received a grant of 63,600 shares at no co", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-0610e00e1c00.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:40:25", "published_display": "02 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) COO granted RSUs, performance rights and sells shares", "summary": "Cerus Corp's COO, Vivek K. Jayaraman, received significant equity grants including 554,529 shares of common stock and 369,686 performance rights, with vesting contingent on continued service and the company's stock performance. Concurrently, he sold 42,359 shares worth approximat", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-d9960180595b.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:40:25", "published_display": "02 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (NASDAQ: CERS) CLO reports Rule 10b5-1 tax sale and 55,000-share grant", "summary": "Cerus Corp's Chief Legal Officer, Chrystal Jensen, reported two common stock transactions on June 30, 2026. Jensen sold 24,329 shares at a weighted average price of $2.9429 to cover tax withholding obligations and brokerage fees related to vesting restricted stock units under a R", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-6afca42325b7.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:40:25", "published_display": "02 Jul 2026 23:40", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "CERUS (CERS) CEO Greenman logs tax-related share sale and 192,500-share grant", "summary": "CERUS (CERS) President and CEO William Mariner Greenman reported a tax-related sale of 101,919 shares to cover withholding and brokerage fees, alongside receiving a grant of 192,500 shares at no cost. These transactions, conducted under a Rule 10b5-1 plan, resulted in a net incre", "url": "https://www.stocktitan.net/sec-filings/CERS/form-4-cerus-corp-insider-trading-activity-803acf48e8f1.html", "source_name": "Stock Titan", "published_at": "2026-07-02T23:09:24", "published_display": "02 Jul 2026 23:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Institutional Confidence", "summary": "Cerus Corp (CERS) has an institutional shareholding score of 7.00, placing it 79th out of 203 in the Healthcare Equipment & Supplies industry. Institutional investors hold 73.57% of the shares, a slight decrease of 1.81% quarter-over-quarter. Catherine Wood is the largest institu", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/sentiment", "source_name": "TradingKey", "published_at": "2026-06-18T17:10:14", "published_display": "18 Jun 2026 17:10", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Financial Health: Profitability & Balance Sheet Analysis", "summary": "Cerus Corp (CERS) currently holds a financial score of 8.05, placing it 48th out of 203 in the Healthcare Equipment & Supplies industry, indicating stable financial health and high operating efficiency. The company recently reported a quarterly revenue of $59.89 million, marking ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/financial-health", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:30", "published_display": "18 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 74, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus to Showcase New Evidence, Innovation and Global Experience with the INTERCEPT Blood System at the 39th International ISBT Congress", "summary": "Cerus Corporation announced its participation in the 39th International ISBT Congress in Kuala Lumpur, Malaysia, from June 20-24, 2026. The company will host a symposium and present abstracts highlighting the INTERCEPT Blood System's role in enhancing blood safety, operational ef", "url": "https://finance.yahoo.com/healthcare/articles/cerus-showcase-evidence-innovation-global-123000733.html", "source_name": "Market source", "published_at": "2026-06-18T05:09:30", "published_display": "18 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 72, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Technical Analysis: Support, Resistance, Indicators & Moving Averages", "summary": "This article provides a technical analysis of Cerus Corp (CERS), detailing its current price momentum, support and resistance levels, and signals from various technical indicators and moving averages. The stock is currently trading between resistance at $3.08 and support at $2.36", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/technical", "source_name": "TradingKey", "published_at": "2026-06-18T05:09:30", "published_display": "18 Jun 2026 05:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Earnings Forecast: Future EPS & Revenue Growth Estimates", "summary": "Cerus Corp (CERS) has an earnings forecast score of 8.67, ranking 16th in the Healthcare Equipment & Supplies industry, with an average analyst price target of $5.00. Based on ratings from 3 analysts, the stock has a \"Buy\" trend. The expected revenue for the next quarter is $60.9", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/earnings", "source_name": "TradingKey", "published_at": "2026-06-18T04:03:00", "published_display": "18 Jun 2026 04:03", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution", "summary": "This article provides a detailed revenue breakdown for Cerus Corp (CERS) based on its business segments and regional contributions. For the fiscal year 2025, Product revenue accounted for 88.17% ($206.13M) and Government Contract revenue for 11.83% ($27.66M). Geographically, the ", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/revenue", "source_name": "TradingKey", "published_at": "2026-06-17T21:13:07", "published_display": "17 Jun 2026 21:13", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Shareholder Structure: Major Shareholders & Institutional Holdings", "summary": "This article details the shareholder structure of Cerus Corp (CERS), highlighting major shareholders and institutional holdings. It provides a breakdown of shareholder types, institutional shareholding over several quarters, and a list of key shareholder activities with changes i", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/ownership", "source_name": "TradingKey", "published_at": "2026-06-17T14:09:35", "published_display": "17 Jun 2026 14:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Dividends & Stock Splits: Historical Payouts and Event Timeline", "summary": "This article provides an overview of Cerus Corp (CERS)'s dividend and stock split history, noting that the company has distributed $0.00 in dividends over the past five years and has no recorded stock splits. It also includes current stock performance metrics such as a +8.50% gai", "url": "https://www.tradingkey.com/markets/stocks/nasdaq-cers/dividend-splits", "source_name": "TradingKey", "published_at": "2026-06-17T13:09:35", "published_display": "17 Jun 2026 13:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "capital_return", "event_label": "Capital return", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus takes INTERCEPT blood system data to global transfusion congress", "summary": "Cerus Corporation (Nasdaq: CERS) announced its participation in the 39th International ISBT Congress in Kuala Lumpur, Malaysia, from June 20-24, 2026. The company will host a symposium and present abstracts highlighting the INTERCEPT Blood System's effectiveness in enhancing bloo", "url": "https://www.stocktitan.net/news/CERS/cerus-to-showcase-new-evidence-innovation-and-global-experience-with-pmi2meq1qbo6.html", "source_name": "Stock Titan", "published_at": "2026-06-17T12:09:34", "published_display": "17 Jun 2026 12:09", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) Closes New Debt Facility of Up to $110M", "summary": "Cerus Corporation has secured a new debt facility of up to $110 million with MidCap Financial, combining a five-year term loan with an asset-backed revolving loan. This refinancing is expected to reduce annual cash interest expenses by up to $3.5 million and lowers the outstandin", "url": "https://finance.yahoo.com/markets/stocks/articles/cerus-corporation-cers-closes-debt-125301266.html", "source_name": "Market source", "published_at": "2026-06-16T12:39:19", "published_display": "16 Jun 2026 12:39", "sentiment": "positive", "sentiment_pct": 74, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "5 Best Genomics Stocks to Buy According to Analysts", "summary": "This article identifies Cerus Corporation (NASDAQ: CERS) as a top genomics stock to buy, with analysts projecting a 66.05% upside potential. Cerus recently secured a new debt facility of up to $110 million, which is expected to cut annual cash interest expenses by up to $3.5 mill", "url": "https://www.insidermonkey.com/blog/5-best-genomics-stocks-to-buy-according-to-analysts-1780200/3/", "source_name": "Insider Monkey", "published_at": "2026-06-14T11:15:00", "published_display": "14 Jun 2026 11:15", "sentiment": "positive", "sentiment_pct": 73, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation Closes New Debt Facility of Up to $110 Million", "summary": "", "url": "https://finance.yahoo.com/markets/stocks/articles/cerus-corporation-closes-debt-facility-123000605.html", "source_name": "Business Wire", "published_at": "2026-06-08T12:30:00+00:00", "published_display": "08 Jun 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "liquidity", "event_label": "Balance sheet", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Should I buy Cerus (CERS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMibEFVX3lxTE9zWDNZR2Q1aGh2akVQSU1VbGJNeDY4eHJtVEd4ZzdmaWV1dkFfYjNJd2c3LVpla2w2VVMzOXVkaHZvZHZua2thR2doLWtIZUFlTUc4YVUyTGdsdy1sVG8ycjAtdC1hQlVRZkQwcg?oc=5", "source_name": "Zacks Investment Research", "published_at": "2026-06-04T07:00:00+00:00", "published_display": "04 Jun 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Significant Cerus shareholder to oppose CEO and pay chair at June 2 vote", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQQW53MnhYTmU1bDRsU1NTS0FEOURPbnVYWDFpSzlNV05ZNlQwMFVHeFdCcXJhNmpmWmM4SWlfTFBCY1lTM3NTLUpraEQ1dmVPa29nRFItTmxoclJxTWxHOFNrWjRUZkgwTnFCLWpocFNGWXVqWE1UNGVsUlhfNVgzRFlCMlcyN1Nack5Xb0NJZVVyOXBzNzRiVThVRjJxaGdkRmc2UkV1QTZWTjdPUnFYWE9xWFV2ZTYydmR5bm5R?oc=5", "source_name": "Stock Titan", "published_at": "2026-05-27T07:00:00+00:00", "published_display": "27 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) Gets Upgraded to Buy Post Q1 by BTIG", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxQSXBzZklWbjJFTHpsSjZwTjQ3ZHcxb2tGeVRaNUlFaG1ESEJZN2JJUTRNcVBiNkRZVHZKcVlEa21LeFEyc2pXMmhVbVZZUFFXV0M3b0YxcHdDZzh3MVYtbEF4RTJqM2ZMVGhaYXp3czVNTUJoT1RYaDE4cWVRbmc4a3pSZTk2MS1Zb2N4R3pEME5odkVSemlDSEhmRWFRYzJOVlZhT2NONS0?oc=5", "source_name": "Market source", "published_at": "2026-05-23T07:00:00+00:00", "published_display": "23 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 84, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 69, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation: Strong Q1 Results Validate The Turnaround Thesis (NASDAQ:CERS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiswFBVV95cUxOdVBuY1VHWnBHeDdoQVRkdGEwc2FmV0t0UG92a2JWOWZvNlM2T29JQk1LcDBuWnJ2UV9BS05KQnlobGY5amx4X245bWlUZzZSbk9tR3FhVHlHeUFHYjZmRHctNFF0QjMydHhlYjVyWXFzTHhvdWdNUjBqcGFLTUpWSTFucXNtNFl0V19xMnQ2OVlYdkludzV6QXEtendMRWNENFg2QUtUSFJhZjg1V0FDaXdISQ?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-05-10T07:00:00+00:00", "published_display": "10 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation Q1 2026 Earnings Call Summary", "summary": "", "url": "https://finance.yahoo.com/m/d5ab6c75-7b71-3df5-b161-3c5f91b420d6/cerus-corporation-q1-2026.html", "source_name": "Moby", "published_at": "2026-05-01T12:30:00+00:00", "published_display": "01 May 2026 12:30", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corp (CERS) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...", "summary": "", "url": "https://finance.yahoo.com/sectors/healthcare/articles/cerus-corp-cers-q1-2026-071759355.html", "source_name": "GuruFocus.com", "published_at": "2026-05-01T07:17:59+00:00", "published_display": "01 May 2026 07:17", "sentiment": "positive", "sentiment_pct": 66, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) Q1 2026 Earnings Transcript", "summary": "", "url": "https://news.google.com/rss/articles/CBMingFBVV95cUxQNnRSUzJILXdnN2h4a2RUNEFSMFZkbUx4TlViOW9SME1uMktvS0Rzbmw0STd5bDJDYmpJcm5VNVV4dUtRX0g2RmMxOUV0Zk5UdVM3dExYX2wtQVFfYXNOM1dIazFQLTFKbTJZNndZNVliblQ3ekVnVVpnOXZtZWU1dVFVakN4LVlFVkwtRW9iLXZQSmhHTFYxUm5xTVF5UQ?oc=5", "source_name": "The Motley Fool", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation Announces First Quarter 2026 Financial Results", "summary": "", "url": "https://news.google.com/rss/articles/CBMivgFBVV95cUxQYjRjWmtvX09RMlZiQ1Z6ZTE5RzgyZU5hOVlmcjhRanZ4aFFIMGwzQUUzOFdJOExhYWw4LU14SEFzY29SMU9rbVZUc3VhR1o4QURtR0VpNm4tMGUtTlZWbXRZU0FIaEZ6bFlOWmM2UXNfSjU3SGRINUctcExfTnFaZTJMMEo1VnRWYlRpNDVaMTNKQ1JMTzJ1Q21DaWpyX1p4cUNyNnhxUWgxWWhWSkFSeFRBcS15MWh3LXhOejF3?oc=5", "source_name": "Business Wire", "published_at": "2026-04-30T07:00:00+00:00", "published_display": "30 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus wins 4-year deal with French blood network serving 330,000 units", "summary": "", "url": "https://news.google.com/rss/articles/CBMiugFBVV95cUxNUG1iM3NNVnJXMVZyMHQ1WkJQNnExSU92Y3J3Y1A0Z0Q4b3ZYQnUxUlFRcUQyZVZkbGI3NHNpYl81V190X1paS3pWbzlxV1puTVdpMmZ0anc5di1aQ2lIUmZpd0c5YV9LblJuYkg3VGY1d28xNGxuNHBBX1dYVU1UeDBYN2NxMFU0RVQtLTYxSTRzSGxsSjIwVEhHNG1Ldjg5cmJ0MGVmWjBFdUNhRHRrMTl0YjhESUR5UVE?oc=5", "source_name": "Stock Titan", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "deals", "event_label": "Deals and strategy", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus' Record 2025 Sets It Up For Another Leg Higher (NASDAQ:CERS)", "summary": "", "url": "https://news.google.com/rss/articles/CBMilwFBVV95cUxQQzg4SWx0N1plVVg2TTBaMjNYZEtnZnFfalpNUFk1RFpzZTY2ekdXUmVlcXhDeVFQUXdGaEZCT19LYnllcF9DMFU2RW5pTUFPTkhjZ0JSVzhIT0N0YU1fTjREdzlFVFozOGx5Uk5rSjhJbEZYbnBMVUREdUxVaDFaZG5TamJKQ1NsZkhHZmRUaE5GLXVYNW9J?oc=5", "source_name": "Seeking Alpha", "published_at": "2026-03-05T08:00:00+00:00", "published_display": "05 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 82, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-03-04T08:00:00+00:00", "published_display": "04 Mar 2026 08:00", "sentiment": "positive", "sentiment_pct": 95, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 61, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOXzRWMWVJQjBISUp5U2JSSDlqQmYxdHVSMnF4U0JmSDJNTy1NR3hfSzgxV3pNYVFrX1oxME1EVjM4LUQ5V2Q5TV9zVHUyaXV3OU9IYURjRVVoS1NDd29ET0I1Z2VPV0hMXzJ6X09BWnYzVkJqaVhIMlh3bGs4dUxwRnZGZVhyRnpIclg4QUhscDlDZk5PVkJPNw?oc=5", "source_name": "Quiver Quantitative", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Corporation (NASDAQ:CERS) Held Back By Insufficient Growth Even After Shares Climb 27%", "summary": "", "url": "https://news.google.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?oc=5", "source_name": "simplywall.st", "published_at": "2026-01-23T08:00:00+00:00", "published_display": "23 Jan 2026 08:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus Markets Review 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMiZ0FVX3lxTE05aHAtTmIwUmpuLTlaUWs0OHdQY1VMNGxDNjBMMmVLV3d0cVZKazVBNU9tUnZxeXFEdy1DLWttbXdqaEF0SnlSSDZlQmoza19qeE5LSlJNdUdKN2lRRlQ3MVJKMjFTQlk?oc=5", "source_name": "Investing.com", "published_at": "2024-07-15T07:00:00+00:00", "published_display": "15 Jul 2024 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Cerus (CERS) Stock Price, News & Analysis $CERS", "summary": "", "url": "https://news.google.com/rss/articles/CBMiWkFVX3lxTE5Kd1ZTY3FkTjZ2aUdSWHhhaEl0T2lTZE41LUhsTkRZaDdCQlAtTlpuNG5rUzlCZUZwajdPRXQ3T3FiSmRFV1piY0ZqdzU1UmhDc29xUnl1WXRTZw?oc=5", "source_name": "MarketBeat", "published_at": "2016-08-15T18:25:47+00:00", "published_display": "15 Aug 2016 18:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [{"title": "Reflecting On Medical Devices & Supplies - Specialty Stocks\u2019 Q1 Earnings: Integer Holdings (NYSE:ITGR)", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNUFd1SUpRcWlCdEFjU1YzNTZkdjBfRkwyY2lBYjh1ZXZlZTlyVlpWSWx1bExvckFrNHNhUEdVTGNFWUxaMkVDZUV2c2hPS1h2YVhNSHNsVzFYNUFrNHBnRVM1STRsa2Zmb0VXeEQ4UFRGNDBOWXZfWVU5VFUyQ3JZZm9KamZMWXVDSEtNMWwyVktpaEZfRjVNU1BYaWJ3NnpNUmRyMEpsSzBXdw?oc=5", "source_name": "Market source", "published_at": "2026-07-14T18:07:11+00:00", "published_display": "14 Jul 2026 18:07", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks Q1 Earnings: ICU Medical (NASDAQ:ICUI) Firing on All Cylinders", "summary": "", "url": "https://news.google.com/rss/articles/CBMikAJBVV95cUxQLWl0NWl5MFJhUXFSN0pzSW1sVzJVb21XVml0X0doQnd5eDVUQmVqeFZWSmNmdlZaV2pfbFk3UEl3RXlqZ05pckozR0dnNHNEUlpTa2FPYWc1Z3Q0Y2tXYTljZUlQRkVZNzY2Sl9yRksyUDJkNVQzSTBuLW9uMnI5bzBfTTJGdDUzd25DN3dDSmhwWnpGVXZRVVM2Uy1zMnp4STZ1RGdZZkRpZ21Pb2xtWjRSTk1kc2JrT28wTG81NDV1M2tWaVdrOXBQdVZSTExiTVEzMXpqRnJWWi0xcEdMYVFILXZXbXZVZl9GRm12aTl5OGk4X1dSVjVyU2FIVFpubk1YNm5fQll0MVZqRTZpTA?oc=5", "source_name": "StockStory", "published_at": "2026-06-15T07:00:00+00:00", "published_display": "15 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q1 Earnings Review: Medical Devices & Supplies - Diversified Stocks Led by Baxter (NYSE:BAX)", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxNYjhBT3BjMWFVU1FFUUFub0d6QUVEUTdwWFVMRG5fN2dHSnIxTXQwMWU1aElKaEV1a2dYLTFHMlBzMVFTZEtaX0xRRDFhZDl1WFdDYWF2RDZxOG9SRUtycmZacTRzM2FaaEU3OS1GZ2taLWtSMjZ4enhVNHRvdzJsanp4cEhNcGI1dllTOUplWUUtNjRlRm85MlFEVWxSYUV2d243QVd3?oc=5", "source_name": "Market source", "published_at": "2026-05-21T07:00:00+00:00", "published_display": "21 May 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Medical Devices & Supplies - Specialty Q4 Earnings: Globus Medical (NYSE:GMED) is the Best in the Biz", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqgFBVV95cUxNcDFMNmtOVk5PVFM1YzMyVWhyS3dwY0dMVE5BUng5U1JoOFRQMXNFRGxTMmlBRUV0bENRSWFXTDFZOXBQQkNZT0FOWDdISjRCcU9pRV9aNHBwUVBuZkVEV3g1dklVY19KOE9iWUNpNUtMS2NuOEcxMlQtNU8ydURybEdkNVoxZThWLTBIeVhid2NjQ0FWWTUzb2dxcmlMQThFQmZ4bldzRjcwUQ?oc=5", "source_name": "Market source", "published_at": "2026-04-27T07:00:00+00:00", "published_display": "27 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "A Look Back at Medical Devices & Supplies - Imaging, Diagnostics Stocks\u2019 Q4 Earnings: Hologic (NASDAQ:HOLX) Vs The Rest Of The Pack", "summary": "", "url": "https://news.google.com/rss/articles/CBMipgFBVV95cUxOdkl6Ym5HSGVhZUw3TzNlNVFPSjdDQk5NMTVSRW1xVnh3RE5RNU9veVR0TDEtcVdxV3BYelI0bWxCYXgwWmhZQ3ZONUVRdlhjX0ZiMklRVDJQRXN0LXcyVWVnb0E2WTdiRERtZk1pNGpmVHhWbHl5eHJuNnBtTDVPMUluTmRsQUVqYjNlSl8zR3djclh0X2ZIc1gzTlhPanR6ZTJ6R1FB?oc=5", "source_name": "Market source", "published_at": "2026-04-07T07:00:00+00:00", "published_display": "07 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: Artivion (NYSE:AORT) Vs The Rest Of The Medical Devices & Supplies - Cardiology, Neurology, Vascular Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMiqAFBVV95cUxPaTgxS3dlMlZ5dDZ3dFlGdG9yRWFubkVqMk9yOTN6OEtyemljTWJGYUcxb2pmd2FTNTFKMlhIVGxrdlJsOG5iY1VQaXE4ZmYycTVpRkE0aEJ3QlB5bC10ZXN2dTFYNy0wRWdrNURVUlo5dEMzQklxQ0kwQTRkOXE0UDdTMkRGRWxoQ1ZQeG4tOXNONlR2SkxfZW5ST1B6N3BBeFZZQ3N1UFE?oc=5", "source_name": "Market source", "published_at": "2026-04-02T07:00:00+00:00", "published_display": "02 Apr 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highlights: CooperCompanies (NASDAQ:COO) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMitAFBVV95cUxOellVLTAtRXF1dTFacmVLUmptUVpDSkxGX0MtY2hCY2l3ajU4M25SMG95OHdlc1RHN1dmaHZZMF9uQ0o3R1FBa0NzQUtZMjIzMjU1bmttbGZsZUplQkd5Vmd2NEJoQ0NnbVhmVXppdWhiQkdpcGpQVFJVSHRBXy1pbnFJbXI0R2w3MmlvMEdCY2dGYVE4cWY2MENmeEp1ME9mZEFqSDVtdThTMk9kbUhIdXMtR0k?oc=5", "source_name": "Market source", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Integer Holdings (NYSE:ITGR) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihAJBVV95cUxNdFRrRlJvM3J3cGJnVEJ6ZndqMnQxWkE4Wm8zTGtPTVc0OTlLN1pwNXIyclNJMFZkcG5qQTRTWThmNm9WN0hKYXBja3N3Y20zSlkxc2JaQlpYTnAyWnpvUVBvR1JWNmVxZGhSYVlYQklMd01GeFBVNGJWOFBWYUkwYmRrM2xrSktiQWpfTkZtNG1HWThNT0tqLUpYek5qcnFWMGE0QV9CaElrMUpfTEhnOC1pS2t1bkE2VVJHdEhWdEtoX2xKNE1MWk1OSlBSNTVZVU83WEpnb3E4aURwQ3ZyZUFDbndpTTZEa0lZRTJvU2VuTDhreXdCQ25iV3Y4YWxENm1xYQ?oc=5", "source_name": "StockStory", "published_at": "2026-03-16T07:00:00+00:00", "published_display": "16 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxPeVpVN2I3X3lJNXd3TXJmRWV4X0RvRDdYR3l5a1k1SjMxUlhsWHdrUUNuZ1JIaUg4czdhZlA2VDVIallROFFuNmZXcnNzS1d3Vm0wS0tLMmlFVWdkUThsRDZYdTdZV3k3WkRjaUZSMUQ3dkRKYm5ZOVBjMVVBdTRjYQ?oc=5", "source_name": "Market source", "published_at": "2026-03-12T07:00:00+00:00", "published_display": "12 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Unpacking Q4 Earnings: Enovis (NYSE:ENOV) In The Context Of Other Medical Devices & Supplies - Specialty Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMihgFBVV95cUxNMzBPcXU1cnZKekZnaGlNVk05ZWFTWThNOS0tTlpvQjdaLVZIWlVXUk50NnVoQ0pPWWJpZUpWcVJyVDJMd2RJREVDbEEzTlU5UGhBbWtxWVEyVkdaMTVuNXZpaWFMNTZUQ2d0OW9Rc29kalJRY21naWlHZDBLS3RuZV9wdTdIUQ?oc=5", "source_name": "Market source", "published_at": "2026-03-10T07:00:00+00:00", "published_display": "10 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}, {"title": "Q4 Earnings Highs And Lows: Baxter (NYSE:BAX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAFBVV95cUxOb3BiQVNFREdNblk2QS10b1lhRUtfb05vU2VFZHB5V0hJT0R4NmhwQWRrcFVsR3UwMjZleFV6N2FEelpZVzY3YWFxSWE1cWpLaTFrQVU4NktkQUloUkxaV3ZTVkh6b1ZmaDdMN2ViX1BUNE4xUTNUZFNlR0syVGlZSg?oc=5", "source_name": "Market source", "published_at": "2026-03-02T08:00:00+00:00", "published_display": "02 Mar 2026 08:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "industry", "tier_label": "Industry context"}], "sector": []}, "total_fetched": 94, "total_relevant": 55, "sentiment_summary": {"positive": 17, "negative": 0, "neutral": 38, "score": 57, "total": 55, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 76, "events": [{"event": "general", "label": "Market update", "weight": 13.35, "count": 23}, {"event": "earnings", "label": "Earnings", "weight": 12.04, "count": 24}, {"event": "liquidity", "label": "Balance sheet", "weight": 1.65, "count": 3}, {"event": "analyst", "label": "Analyst action", "weight": 1.1, "count": 2}, {"event": "regulatory", "label": "Regulatory and legal", "weight": 0.55, "count": 1}, {"event": "capital_return", "label": "Capital return", "weight": 0.55, "count": 1}], "positive_events": 17, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 3.12, "latest_week": "2026-07-10", "one_week_move": -1.3, "four_week_move": 21.9, "twelve_week_move": 50.0, "trend_signal": "1", "trend_label": "Trend active", "trend_tone": "positive", "market_dynamics": 1.032355, "market_dynamics_buy_signal": false, "relative_strength": 36.299523, "fair_value_gap": 68.8, "fair_value_label": "Materially above fair value", "fair_value_tone": "negative", "expectation_direction": "negative", "expectation_probability": 43.606, "reaction_label": "Price digesting", "reaction_tone": "neutral", "market_sentence": "-1.3% over one week, +21.9% over four weeks, trend active, and materially above fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": [], "opportunities": [], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Market source", "count": 12}, {"label": "Stock Titan", "count": 10}, {"label": "TradingKey", "count": 7}, {"label": "Business Wire", "count": 3}, {"label": "Investing.com", "count": 3}, {"label": "AD HOC NEWS", "count": 2}, {"label": "StockStory", "count": 2}, {"label": "Seeking Alpha", "count": 2}], "tiers": [{"label": "Direct company coverage", "count": 44}, {"label": "Industry context", "count": 11}, {"label": "Sector context", "count": 0}], "events": [{"label": "Earnings", "count": 24}, {"label": "Market update", "count": 23}, {"label": "Balance sheet", "count": 3}, {"label": "Analyst action", "count": 2}, {"label": "Regulatory and legal", "count": 1}, {"label": "Capital return", "count": 1}, {"label": "Deals and strategy", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "57/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "76/100 classification confidence."}, {"label": "Company focus", "value": "44", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "3", "tone": "positive", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend active", "tone": "positive", "text": "-1.3% over one week, +21.9% over four weeks, trend active, and materially above fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "Cerus Corporation to release Q2 2026 results on July 30"}], "updated_at": "2026-07-17T09:16:10.094102+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}